Dual targeting carbonic anhydrase inhibitors as promising therapeutic approach: a structural overview. [PDF]
D'Ambrosio K, Di Fiore A, Langella E.
europepmc +1 more source
Carbonic anhydrase inhibitors prevent presymptomatic capillary flow disturbances in a model of cerebral amyloidosis. [PDF]
Gutiérrez-Jiménez E +20 more
europepmc +1 more source
4-Substituted Pyridine-3-Sulfonamides as Carbonic Anhydrase Inhibitors Modified by Click Tailing: Synthesis, Activity, and Docking Studies. [PDF]
Szafrański K +6 more
europepmc +1 more source
Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors. [PDF]
openaire +2 more sources
Insight on novel sulfamoylphenyl pyrazole derivatives as anticancer carbonic anhydrase inhibitors. [PDF]
Ahmed RF +5 more
europepmc +1 more source
Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in <i>Trypanosoma cruzi</i>: Virtual Screening and In Vitro Studies. [PDF]
Ortiz-Pérez E +10 more
europepmc +1 more source
Efficacy of topical carbonic anhydrase inhibitors in treating taxane drug-induced cystoid macular edema: A case report. [PDF]
Hou X, Chen D, Lu Y.
europepmc +1 more source
Comparative efficacy of selenoureido carbonic anhydrase inhibitors and azole antifungal drugs against clinical isolates of Malassezia pachydermatis. [PDF]
Spadini C +11 more
europepmc +1 more source
Melanin-Binding-Based Discovery of Topically Instilled Carbonic Anhydrase Inhibitors for Targeted Delivery and Prolonged Action in the Eye. [PDF]
Valtari A +11 more
europepmc +1 more source
Pegylation approach applied to erlotinib-carbonic anhydrase inhibitors hybrids towards anticancer agents. [PDF]
Filiberti S +12 more
europepmc +1 more source

